Jeffreys Drug Store
Letter data
- Company
- Jeffreys Drug Store
- Recipient
- Jeffreys Drug Store | United States
- Issue date
- 2018-08-16
- Posted date
- Not available
- FDA office
- United States
- Subject
- Not available
- Product
- Not available
- CMS ID
- 495144
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Jeffreys Drug Store
MARCS-CMS 495144 —
August 16, 2018
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Recipient:
Jeffreys Drug Store
United States
Issuing Office:
United States
Division of Pharmaceutical Quality Operations I
10 Waterview Blvd, 3rd Floor
Parsippany, NJ 07054
Telephone:
(973) 331-4900
FAX:
(973) 331-4969
VIA UNITED PARCEL SERVICE
August 16, 2018
Gerald E. O’Hare, R. Ph.
President
Jeffreys Drug Store
1 N. Central Avenue
Canonsburg, PA 15371
Dear Mr. O’Hare:
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter # 16-PHI-12 dated August 25, 2016. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Stephanie Durso
OPQO Division I Director Compliance Branch
Content current as of:
09/17/2018